Uncategorized

Shanghai Junshi Biosciences Co., Ltd, announced its financial results for the full year of 2023 and provided corporate updates.

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare’s novel SHP2.

Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results.

The draft plan builds on its predecessor, which the health IT agency said drove “significant progress” in the use and exchange of electronic health information.

The retail pharmacy chain has closed 140 VillageMD locations to date to cut costs, blowing past its previous goal of 60 closures.

The company pegged related severance costs at about $4 million to $8 million but did not say how many employees could be affected.

It’s the “most robust and meaningful” regulation streamlining Medicaid eligibility since the Affordable Care Act was implemented a decade ago, one lawyer said.

Medtech dealmaking has not yet taken off this year, but there have been a number of smaller tuck-in acquisitions and private equity agreements.

The pharmaceutical industry is facing critical attention, particularly around drug pricing and development costs. Drug development cost is about 10% of the total healthcare spend in the United States. Broader issues such as local monopolies, utilization, unit, and costs and local monopolies, politics and a fragmented payer system contribute to the increasingly high costs to

Los códigos QR, abreviatura de “Quick Response” o respuesta rápida en español, son una especie de código de barras bidimensional que almacena datos de manera eficiente. Pueden contener una variedad de información, como enlaces a sitios web, informaci&oacu …